Home/Prosetta Biosciences/Thomas Higgins
TH

Thomas Higgins

Chairman of the Board

Prosetta Biosciences

Prosetta Biosciences Pipeline

DrugIndicationPhase
PAV-615 (Neuroscience)C9orf72-associated ALS/FTDPreclinical
Neuroscience ProgramAlzheimer's DiseasePreclinical
Antiviral ProgramBroad-spectrum (RSV, Influenza, etc.)Preclinical
Oncology ProgramBroad anti-proliferative (multiple cancers)Preclinical
Antibacterial ProgramBacterial infectionsPreclinical
HIV ProgramHuman Immunodeficiency VirusPreclinical